{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:20:34Z","timestamp":1784557234373,"version":"3.55.0"},"reference-count":28,"publisher":"Bioscientifica","issue":"5","content-domain":{"domain":["erc.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2,27]]},"abstract":"<jats:p>\n                    Pheochromocytomas and paragangliomas (PPGLs) are defined as neuroendocrine tumors that produce catecholamines. Many recent advances in their management, localization, treatment, as well as surveillance have significantly improved outcomes for patients with PPGLs or carriers of pathogenic genetic variants linked to the development of these tumors. At present, those advances mainly include the molecular stratification of PPGLs into seven clusters, the 2017 WHO revised definition of these tumors, the presence of specific clinical features pointing toward PPGL, the use of plasma metanephrines and 3-methoxytyramine with specific reference limits to assess the likelihood of having a PPGL (e.g. patients at high and low risk) including age-specific reference limits, nuclear medicine guidelines outlining cluster- and metastatic disease-specific functional (here mainly positron emission tomography and metaiodobenzylguanidine scintigraphy) imaging in the precise diagnostic localization of PPGLs, the guidelines for using radio- vs chemotherapy for patients with metastatic disease, and the international consensus on initial screening and follow-up of asymptomatic germline\n                    <jats:italic>SDHx<\/jats:italic>\n                    pathogenic variant carriers. Furthermore, new collaborative efforts particularly based on multi-institutional and worldwide initiatives are now considered key forces in improving our understanding and knowledge about these tumors and future successful treatments or even preventative interventions.\n                  <\/jats:p>","DOI":"10.1530\/erc-23-0030","type":"journal-article","created":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T05:56:28Z","timestamp":1678254988000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":0,"title":["International symposium on pheochromocytoma: an event of dedicated healthcare professionals and researchers striving for better patient outcomes"],"prefix":"10.1530","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3541-3767","authenticated-orcid":true,"given":"Karel","family":"Pacak","sequence":"first","affiliation":[{"name":"Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1545-0368","authenticated-orcid":true,"given":"Roderick","family":"Clifton-Bligh","sequence":"additional","affiliation":[{"name":"Department of Endocrinology Royal North Shore Hospital, University of Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"bib1","series-title":"Nature Reviews. Endocrinology","first-page":"435","article-title":"International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers","volume":"17","author":"Amar","year":"2021","unstructured":"Amar LPacak KSteichen OAkker SAAylwin SJBBaudin EBuffet ABurnichon NClifton-Bligh RJDahia PLM, 2021International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers. Nature Reviews. Endocrinology17435\u2013444. (https:\/\/doi.org\/10.1038\/s41574-021-00492-3)34021277"},{"key":"bib2","series-title":"Lancet Diabetes Endocrinol","first-page":"13","article-title":"Maternal and fetal outcomes in phaeochromocytoma and pregnancy: a multicentre retrospective cohort study and systematic review of literature","volume":"9","author":"Bancos","year":"2021","unstructured":"Bancos IAtkinson EEng CYoung WFNeumann HPH, International PheochromocytomaandPregnancy StudyGroup2021Maternal and fetal outcomes in phaeochromocytoma and pregnancy: a multicentre retrospective cohort study and systematic review of literature. Lancet Diabetes Endocrinol913\u201321. (https:\/\/doi.org\/10.1016\/S2213-8587(2030363-6)33248478"},{"key":"bib3","series-title":"Journal of Medical Genetics","first-page":"785","article-title":"International initiative for a curated SDHB variant database improving the diagnosis of hereditary paraganglioma and pheochromocytoma","volume":"59","author":"Ben Aim","year":"2022","unstructured":"Ben Aim LMaher ERCascon ABarlier AGiraud SErcolino TPigny PClifton-Bligh RJMirebeau-Prunier DMohamed A, 2022International initiative for a curated SDHB variant database improving the diagnosis of hereditary paraganglioma and pheochromocytoma. Journal of Medical Genetics59785\u2013792. (https:\/\/doi.org\/10.1136\/jmedgenet-2020-107652)"},{"key":"bib4","series-title":"Journal of Clinical Endocrinology and Metabolism","article-title":"Surveillance improves outcomes for carriers of SDHB pathogenic variants: a multicenter study","volume":"107","year":"2022","unstructured":"Davidoff DF, Benn DE, Field M, Crook A, Robinson BG, Tucker K, De Abreu Lourenco R, Burgess JR & Clifton-Bligh RJ, Burgess JR & Clifton-Bligh RJ2022Surveillance improves outcomes for carriers of SDHB pathogenic variants: a multicenter study. Journal of Clinical Endocrinology and Metabolism107 e1907\u2013e1916. (https:\/\/doi.org\/10.1210\/clinem\/dgac019)35037935"},{"key":"bib5","series-title":"Endocrine-Related Cancer","first-page":"757","article-title":"Developmental role of PHD2 in the pathogenesis of pseudohypoxic pheochromocytoma","volume":"28","year":"2021","unstructured":"Eckardt L, Prange-Barczynska M, Hodson EJ, Fielding JW, Cheng X, Lima JDCC, Kurlekar S, Douglas G, Ratcliffe PJ & Bishop T, Douglas G, Ratcliffe PJ & Bishop T2021Developmental role of PHD2 in the pathogenesis of pseudohypoxic pheochromocytoma. Endocrine-Related Cancer28757\u2013772. (https:\/\/doi.org\/10.1530\/ERC-21-0211)34658364"},{"key":"bib6","series-title":"Pancreas","first-page":"469","article-title":"The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and\/or unresectable pheochromocytoma and paraganglioma","volume":"50","author":"Fishbein","year":"2021","unstructured":"Fishbein LDel Rivero JElse THowe JRAsa SLCohen DLDahia PLMFraker DLGoodman KAHope TA, 2021The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and\/or unresectable pheochromocytoma and paraganglioma. Pancreas50469\u2013493. (https:\/\/doi.org\/10.1097\/MPA.0000000000001792)"},{"key":"bib7","series-title":"Cancer Cell","first-page":"181","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"31","author":"Fishbein","year":"2017","unstructured":"Fishbein LLeshchiner IWalter VDanilova LRobertson AGJohnson ARLichtenberg TMMurray BAGhayee HKElse T, 2017Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell31181\u2013193. (https:\/\/doi.org\/10.1016\/j.ccell.2017.01.001)28162975"},{"key":"bib8","series-title":"Seminars in Nuclear Medicine","first-page":"87","article-title":"Targeted radionuclide therapy: A historical and personal review","volume":"50","author":"Goldsmith","year":"2020","unstructured":"Goldsmith SJ2020Targeted radionuclide therapy: A historical and personal review. Seminars in Nuclear Medicine5087\u201397. (https:\/\/doi.org\/10.1053\/j.semnuclmed.2019.07.006)31843064"},{"key":"bib9","series-title":"Cell Reports","article-title":"Genetic impairment of succinate metabolism disrupts bioenergetic sensing in adrenal neuroendocrine cancer","volume":"40","author":"Gupta","year":"2022","unstructured":"Gupta PStrange KTelange RGuo AHatch HSobh AElie JCarter AMTotenhagen JTan C, 2022Genetic impairment of succinate metabolism disrupts bioenergetic sensing in adrenal neuroendocrine cancer. Cell Reports40 111218. (https:\/\/doi.org\/10.1016\/j.celrep.2022.111218)35977518"},{"key":"bib10","series-title":"Cancer Research","first-page":"1396","article-title":"Neoadjuvant intratumoral immunotherapy with TLR9 activation and anti-OX40 antibody eradicates metastatic cancer","volume":"82","author":"Hong","year":"2022","unstructured":"Hong WXSagiv-Barfi ICzerwinski DKSallets A & Levy R2022Neoadjuvant intratumoral immunotherapy with TLR9 activation and anti-OX40 antibody eradicates metastatic cancer. Cancer Research821396\u20131408. (https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-1382)35135810"},{"key":"bib11","series-title":"Clinical Cancer Research","first-page":"2989","article-title":"High-specific-activity (131)I-MIBG vs (177)Lu-DOTATATE targeted radionuclide therapy for metastatic pheochromocytoma and paraganglioma","volume":"27","author":"Jha","year":"2021","unstructured":"Jha ATaieb DCarrasquillo JAPryma DAPatel MMillo Cde Herder WWDel Rivero JCrona JShulkin BL, 2021High-specific-activity (131)I-MIBG vs (177)Lu-DOTATATE targeted radionuclide therapy for metastatic pheochromocytoma and paraganglioma. Clinical Cancer Research272989\u20132995. (https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-3703)"},{"key":"bib12","series-title":"Cancers (Basel)","article-title":"Targeted radionuclide therapy for patients with metastatic pheochromocytoma and paraganglioma: from low-specific-activity to high-specific-activity iodine-131 metaiodobenzylguanidine","volume":"11","author":"Jimenez","year":"2019","unstructured":"Jimenez CErwin W & Chasen B2019Targeted radionuclide therapy for patients with metastatic pheochromocytoma and paraganglioma: from low-specific-activity to high-specific-activity iodine-131 metaiodobenzylguanidine. Cancers (Basel)111018. (https:\/\/doi.org\/10.3390\/cancers11071018)31330766"},{"key":"bib13","series-title":"BJOG","first-page":"1264","article-title":"Pregnancy and phaeochromocytoma\/paraganglioma: clinical clues affecting diagnosis and outcome - a systematic review","volume":"128","year":"2021","unstructured":"Langton K, Tufton N, Akker S, Deinum J, Eisenhofer G, Timmers H, Spaanderman M & Lenders J & Lenders J2021Pregnancy and phaeochromocytoma\/paraganglioma: clinical clues affecting diagnosis and outcome - a systematic review. BJOG1281264\u20131272. (https:\/\/doi.org\/10.1111\/1471-0528.16635)33342020"},{"key":"bib14","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"1915","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","year":"2014","unstructured":"Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, Naruse M, Pacak K, Young WF & Endocrine Society, Pacak K, Young WF & Endocrine Society2014Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism991915\u20131942. (https:\/\/doi.org\/10.1210\/jc.2014-1498)24893135"},{"key":"bib15","series-title":"Journal of Hypertension","first-page":"1443","article-title":"Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension","volume":"38","author":"Lenders","year":"2020","unstructured":"Lenders JWMKerstens MNAmar LPrejbisz ARobledo MTaieb DPacak KCrona JZelinka TMannelli M, 2020Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. Journal of Hypertension381443\u20131456. (https:\/\/doi.org\/10.1097\/HJH.0000000000002438)"},{"key":"bib16","series-title":"Journal of the American College of Cardiology","first-page":"451","article-title":"Current view: pathophysiology and acute management of tachyarrhythmias in pheochromocytoma","volume":"74","author":"Nazari","year":"2020","unstructured":"Nazari MARosenblum JSHaigney MC & Pacak K2020Current view: pathophysiology and acute management of tachyarrhythmias in pheochromocytoma. Journal of the American College of Cardiology74451\u2013464."},{"key":"bib17","series-title":"Nature Reviews. Endocrinology","first-page":"233","article-title":"Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas","volume":"13","year":"2017","unstructured":"NGS in PPGL (NGSnPPGL) Study Group, Toledo RA, Burnichon N, Cascon A, Benn DE, Bayley JP, Welander J, Tops CM, Firth H, Dwight T, 2017Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas. Nature Reviews. Endocrinology13233\u2013247. (https:\/\/doi.org\/10.1038\/nrendo.2016.185)27857127"},{"key":"bib18","series-title":"European Radiology","first-page":"7227","article-title":"[18F]FDG-PET\/CT radiomics for the identification of genetic clusters in pheochromocytomas and paragangliomas","volume":"32","year":"2022","unstructured":"Noortman WA, Vriens D, de Geus-Oei LF, Slump CH, Aarntzen EH, van Berkel A, Timmers HJLM & van Velden FHP & van Velden FHP2022[18F]FDG-PET\/CT radiomics for the identification of genetic clusters in pheochromocytomas and paragangliomas. European Radiology327227\u20137236. (https:\/\/doi.org\/10.1007\/s00330-022-09034-5)36001126"},{"key":"bib19","series-title":"Endocrine-Related Cancer","first-page":"X9","article-title":"A xenograft and cell line model of SDH-deficient pheochromocytoma derived from Sdhb+\/- rats","volume":"27","author":"Powers","year":"2020","unstructured":"Powers JFCochran BBaleja JDSikes HDPattison ADZhang XLomakin IShepard-Barry APacak KMoon SJ, 2020A xenograft and cell line model of SDH-deficient pheochromocytoma derived from Sdhb+\/- rats. Endocrine-Related Cancer27X9\u2013X10. (https:\/\/doi.org\/10.1530\/ERC-19-0474e)32861212"},{"key":"bib20","series-title":"Metabolism: Clinical and Experimental","article-title":"Targeting pheochromocytoma\/paraganglioma with polyamine inhibitors","volume":"110","author":"Rai","year":"2020","unstructured":"Rai SKBril FHatch HMXu YShelton LKalavalapalli SClick ALee DBeecher CKirby A, 2020Targeting pheochromocytoma\/paraganglioma with polyamine inhibitors. Metabolism: Clinical and Experimental110 154297. (https:\/\/doi.org\/10.1016\/j.metabol.2020.154297)32562798"},{"key":"bib21","series-title":"Metabolites","article-title":"Predicting hypertension subtypes with machine learning using targeted metabolites and their ratios","volume":"12","author":"Reel","year":"2022","unstructured":"Reel SReel PSErlic ZAmar LPecori ALarsen CKTetti MPamporaki CPrehn CAdamski J, 2022Predicting hypertension subtypes with machine learning using targeted metabolites and their ratios. Metabolites12755. (https:\/\/doi.org\/10.3390\/metabo12080755)36005627"},{"key":"bib22","series-title":"JCI Insight","article-title":"Developmental vascular malformations in EPAS1 gain-of-function syndrome","volume":"6","author":"Rosenblum","year":"2021","unstructured":"Rosenblum JSWang HDmitriev PMCappadona AJMastorakos PXu CJha AEdwards NDonahue DRMunasinghe J, 2021Developmental vascular malformations in EPAS1 gain-of-function syndrome. JCI Insight6e144368. (https:\/\/doi.org\/10.1172\/jci.insight.144368)33497361"},{"key":"bib23","series-title":"European Journal of Nuclear Medicine and Molecular Imaging","first-page":"2112","article-title":"European Association of Nuclear Medicine Practice Guideline\/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma","volume":"46","author":"Taieb","year":"2019","unstructured":"Taieb DHicks RJHindie EGuillet BAAvram AGhedini PTimmers HJScott ATElojeimy SRubello D, 2019European Association of Nuclear Medicine Practice Guideline\/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma. European Journal of Nuclear Medicine and Molecular Imaging462112\u20132137. (https:\/\/doi.org\/10.1007\/s00259-019-04398-1)"},{"key":"bib24","series-title":"Human Pathology","first-page":"83","article-title":"Data set for the reporting of pheochromocytoma and paraganglioma: explanations and recommendations of the guidelines from the International Collaboration on Cancer Reporting","volume":"110","author":"Thompson","year":"2021","unstructured":"Thompson LDRGill AJAsa SLClifton-Bligh RJde Krijger RRKimura NKomminoth PLack EELenders JWMLloyd RV, 2021Data set for the reporting of pheochromocytoma and paraganglioma: explanations and recommendations of the guidelines from the International Collaboration on Cancer Reporting. Human Pathology11083\u201397. (https:\/\/doi.org\/10.1016\/j.humpath.2020.04.012)32407815"},{"key":"bib25","series-title":"WHO Classification of Tumours of Endocrine Organs","first-page":"179","author":"Tischler","year":"2017","unstructured":"Tischler ATGill AKawashima AKimura NKomminoth P TG &  P2017. In Lloyd RVOsamura RYKl\u00f6ppel G & Rosai J, Eds. WHO Classification of Tumours of Endocrine Organs (4th ed., pp. 179\u2013207). International Agency for Research on Cancer (International Arctic Research Center)."},{"key":"bib26","series-title":"Seminars in Oncology","first-page":"385","article-title":"Coley's immunotherapy revived: innate immunity as a link in priming cancer cells for an attack by adaptive immunity","volume":"46","year":"2019","unstructured":"Uher O, Caisova V, Hansen P, Kopecky J, Chmelar J, Zhuang Z, Zenka J & Pacak K & Pacak K2019Coley's immunotherapy revived: innate immunity as a link in priming cancer cells for an attack by adaptive immunity. Seminars in Oncology46385\u2013392. (https:\/\/doi.org\/10.1053\/j.seminoncol.2019.10.004)31739997"},{"key":"bib27","series-title":"Molecules","article-title":"Deep membrane proteome profiling reveals overexpression of prostate-specific membrane antigen (PSMA) in high-risk human paraganglioma and pheochromocytoma, suggesting new theranostic opportunity","volume":"26","year":"2021","unstructured":"Vit O, Patel M, Musil Z, Hartmann I, Frysak Z, Miettinen M, Pacak K & Petrak J & Petrak J2021Deep membrane proteome profiling reveals overexpression of prostate-specific membrane antigen (PSMA) in high-risk human paraganglioma and pheochromocytoma, suggesting new theranostic opportunity. Molecules26. (https:\/\/doi.org\/10.3390\/molecules26216567)34770976"},{"key":"bib28","series-title":"Nature Communications","article-title":"Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment","volume":"13","author":"Zethoven","year":"2022","unstructured":"Zethoven MMartelotto LPattison ABowen BBalachander SFlynn ARossello FJHogg AMiller JAFrysak Z, 2022Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment. Nature Communications13 6262. (https:\/\/doi.org\/10.1038\/s41467-022-34011-3)36271074"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/30\/5\/ERC-23-0030.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/erc.bioscientifica.com\/downloadpdf\/journals\/erc\/30\/5\/ERC-23-0030.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/erc.bioscientifica.com\/downloadpdf\/journals\/erc\/30\/5\/ERC-23-0030.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:56:33Z","timestamp":1784555793000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/erc\/article\/25708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,27]]},"references-count":28,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.1530\/erc-23-0030","relation":{},"ISSN":["1351-0088","1479-6821"],"issn-type":[{"value":"1351-0088","type":"print"},{"value":"1479-6821","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,27]]}}}